SMR Resurfacing
Balanced by DesignLimaCorporate’s SMR Resurfacing features an anatomical Design and CTA Option.
Benefits
01
SMR-R is the first modular resurfacing prosthesis.
02
Mini invasive surgical approach instrumentation.
Images
.hd.jpg)
About
The LimaCorporate SMR Resurfacing System is a humeral head resurfacing option, which is part of our SMR modular System.
LimaCorporate has developed the SMR-R System with the following goals in mind:
To re-establish the natural morphology of the humeral head with minimal bone resection
To provide adequate fixation thanks to a titanium plasma spray coating beneath the cup and on the modular peg
SMR Resurfacing offers a straightforward implantation with few surgical steps. It is compatible with cemented and uncemented glenoids.
See bibliography
Bibliography
[1] Bloch H.R. Mid-term clinical outcomes of shoulder resurfacing arthroplasty in correlation to aetiology. J Orthopaed Traumatol. 2011;12(Suppl 1):S31-S32.
[2] Bloch HR. Glenoiditis in shoulder resurfacing arthroplasty, mid-term clinical outcomes in correlation to aetiology. In: Proceedings of the 13th Congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT); 2012 May 23–25; Berlin, Germany.
[3] Merolla G, Bianchi P, Lollino N, Rossi R, Paladini P, Porcellini G. Clinical and radiographic mid-term outcomes after shoulder resurfacing in patients aged 50 years old or younger. Musculoskelet Surg. 2013 Jun;97(Suppl 1):23-9.
[4] Petroff E, Audebert S, Delobelle JM. Cementless surface replacement arthroplasty of the shoulder – a review of 70 cases. J Bone Joint Surg Br. 2012;94-B(Suppl XXXVII):23.
[1] Bloch H.R. Mid-term clinical outcomes of shoulder resurfacing arthroplasty in correlation to aetiology. J Orthopaed Traumatol. 2011;12(Suppl 1):S31-S32.
[2] Bloch HR. Glenoiditis in shoulder resurfacing arthroplasty, mid-term clinical outcomes in correlation to aetiology. In: Proceedings of the 13th Congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT); 2012 May 23–25; Berlin, Germany.
[3] Merolla G, Bianchi P, Lollino N, Rossi R, Paladini P, Porcellini G. Clinical and radiographic mid-term outcomes after shoulder resurfacing in patients aged 50 years old or younger. Musculoskelet Surg. 2013 Jun;97(Suppl 1):23-9.
[4] Petroff E, Audebert S, Delobelle JM. Cementless surface replacement arthroplasty of the shoulder – a review of 70 cases. J Bone Joint Surg Br. 2012;94-B(Suppl XXXVII):23.
Sizing
& Options
Disclaimer
Please note that not all products are available and registered in every market. Please contact your LimaCorporate Sales Representative for any further information.
LPSI, SpaceFlex e SYMBOL® are distributed by Limacorporate S.p.A.
BIOLOX® / BIOLOX®delta / BIOLOX OPTION® is a registered trademark of a company of the CeramTec Group, Germany.
LPSI, SpaceFlex e SYMBOL® are distributed by Limacorporate S.p.A.
BIOLOX® / BIOLOX®delta / BIOLOX OPTION® is a registered trademark of a company of the CeramTec Group, Germany.